Stromal protein ccn family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism

HIGHLIGHTS

• who: . and colleagues from the The University of Texas Health Science Center at San Antonio, United States have published the article: Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism, in the Journal: (JOURNAL)
• what: In this study, tumor purity, leukocyte fraction (LF), cancer cell ploidy, loss of heterozygosity (LOH), and CNV burden were introduced to quantify DNA damage.
• how: The authors introduced ten oncogenic pathway gene sets tumor microenvironment core pathway gene sets metabolic pathway gene sets DDR gene sets extracellular . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.